Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development
Dr. Gladue, an internationally recognized expert in African Swine Fever (ASF) research and development, brings decades of knowledge and experience in ASF vaccine research and development to Seek Labs where he will lead research and development efforts in CRISPR-based veterinary pharmaceutical projects.
- Dr. Gladue, an internationally recognized expert in African Swine Fever (ASF) research and development, brings decades of knowledge and experience in ASF vaccine research and development to Seek Labs where he will lead research and development efforts in CRISPR-based veterinary pharmaceutical projects.
- In his new role with Seek Labs, Dr. Gladue will spearhead veterinary pharmaceutical research utilizing the company’s CRISPR technology.
- His expertise in vaccine development and disease trials is instrumental in enhancing Seek Labs’ research capabilities and development efforts for veterinary applications.
- “Seek Labs is trailblazing new solutions for complex viral diseases like African Swine Fever with their CRISPR technology approach.